Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo

Martin Lehner (Neumarkt, Germany), Jan Seibel, Martin D. Lehner, Jutta Haunschild

Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Session: Novel treatments for cough, asthma, COPD and bronchiectasis
Session type: Thematic Poster Session
Number: 3965
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Martin Lehner (Neumarkt, Germany), Jan Seibel, Martin D. Lehner, Jutta Haunschild. Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo. Eur Respir J 2015; 46: Suppl. 59, 3965

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A fixed combination of thyme and primula dry extracts normalizes goblet cell hyperplasia and MUC5AC formation in vivo and in vitro
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016

A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Potential effect of the extract of zataria multiflora and its consituent carvacrol on lung inflammation of sensitized guinea pigs
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

Mouse pathway biology models: Investigating the biology of alternaria alternata induced lung inflammation in the mouse - Role of ILC2 and Th2 cytokines
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Bcl-2 antagonist ABT-737 attenuates corticosteroid-insensitive neutrophilic airway inflammation
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015


Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

LATE-BREAKING ABSTRACT: MUC1 downregulation induces corticosteroid resistance in asthma’s in vitro and in vivo models
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016

The immunomodulatory activity of protein S protects against allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015


Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

LSC 2014 abstract - Azithromycin lowers mucin production by increasing FOXA2 expression in an IL-13-induced MUC5AC expression model in human bronchial epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014


Farm dust extract increases the epithelial barrier function of bronchial epithelial cells
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014


Toxicological and inflammatory effects of electronic cigarette extracts using in vitro and ex vivo lung models
Source: International Congress 2016 – Electronic cigarettes
Year: 2016